Eisai
4523.T
#2146
Rank
C$12.66 B
Marketcap
C$44.89
Share price
3.73%
Change (1 day)
12.04%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$4.65 Billion

According to Eisai's latest financial reports the company's total liabilities are C$4.65 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31C$4.47 B-6.57%
2022-03-31C$4.79 B16.18%
2021-03-31C$4.12 B-11.97%
2020-03-31C$4.68 B-7.14%
2019-03-31C$5.04 B-4.36%
2018-03-31C$5.27 B3.47%
2017-03-31C$5.09 B11.03%
2016-03-31C$4.59 B-3.86%
2015-03-31C$4.77 B0.05%
2014-03-31C$4.77 B-14.23%
2013-03-31C$5.56 B-20.54%
2012-03-31C$7.00 B-5.56%
2011-03-31C$7.41 B1.13%
2010-03-31C$7.33 B-19.32%
2009-03-31C$9.08 B33.52%
2008-03-31C$6.80 B201.87%
2007-03-31C$2.25 B-1.01%
2006-03-31C$2.27 B-0.96%
2005-03-31C$2.30 B-6.6%
2004-03-31C$2.46 B-2.76%
2003-03-31C$2.53 B13.56%
2002-03-31C$2.23 B-12.08%
2001-03-31C$2.53 B